About: covid:f0b2e5bd613ef1f4c705438cfc29bc822c350d8f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:f0b2e5bd613ef1f4c705438cfc29bc822c350d8f Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Carratalà, Jordi Abelenda-Alonso, Gabriela Ardanuy, Carmen Clemente, Mercedes Gudiol, Carlota Meije, Yolanda Niubó, Jordi Ortega, Lucía Padullés, Ariadna Rombauts, Alexander Tebe, Cristian Videla, Sebastian
is schema:about of	named entity 'antibiotic' named entity 'de-escalation' named entity 'antimicrobial' named entity 'CAP' named entity 'molecular testing' named entity 'phase IV clinical trial' named entity 'molecular testing' named entity 'antibiotic' named entity 'randomisation' named entity 'de-escalation' named entity 'Research Ethics Committee' named entity 'antibiotic' named entity 'heart rate' named entity 'microorganism' named entity 'Europe' named entity 'adverse drug events' named entity 'CAP' named entity 'antimicrobial stewardship' named entity 'Clinical Research' named entity 'Streptococcus pneumoniae' named entity 'Cox proportional hazards models' named entity 'follow-up' named entity 'antibiotic' named entity 'peer-reviewed' named entity 'pneumonia' named entity 'aetiological' named entity 'CONSORT' named entity 'oral antibiotics' named entity 'monotherapy' named entity 'Informed consent' named entity 'control group' named entity 'antimicrobial resistance' named entity 'antimicrobial therapy' named entity 'causative agent' named entity 'infection' named entity 'intervention trial' named entity 'intensive care unit' named entity 'CAP' named entity 'Community-acquired pneumonia' named entity 'respiratory rate' named entity 'complete blood count' named entity 'antimicrobial' named entity 'antibiotics' named entity 'CAP' named entity 'molecular testing' named entity 'randomly assigned' named entity 'antibiotic' named entity 'Spain' named entity 'antibiotic therapy' named entity 'diagnostic process' named entity 'CAP' named entity 'antimicrobial' named entity 'oral antibiotics' named entity 'Survival time' named entity 'S. pneumoniae' named entity 'antimicrobials' named entity 'mechanical ventilation' named entity 'ICU' named entity 'CCI' named entity 'sodium' named entity 'quality assurance' named entity 'Consolidated Standards of Reporting Trials' named entity 'multidisciplinary teams' named entity 'Barcelona' named entity 'amoxicillin' named entity 'comorbidities' named entity 'primary endpoint' named entity 'CCI' named entity 'autonomous community' named entity 'nasopharyngeal' named entity 'phlebitis' named entity 'antibiotic' named entity 'experimental subjects' named entity 'clinical practice' named entity 'antibiotic' named entity 'adverse events' named entity 'blood pressure' named entity 'study population' named entity 'Medical Devices Agency' named entity 'length of hospital stay' named entity 'length of hospital stay' named entity 'Randomisation' named entity 'diagnostic methods' named entity 'immunochromatographic' named entity 'CAP' named entity 'control subjects' named entity 'intravenous' named entity 'length of stay'

Attributes

Values

Creator

Carratalà, Jordi
Abelenda-Alonso, Gabriela
Ardanuy, Carmen
Clemente, Mercedes
Gudiol, Carlota
Meije, Yolanda
Niubó, Jordi
Ortega, Lucía
Padullés, Ariadna
Rombauts, Alexander
Tebe, Cristian
Videla, Sebastian

is schema:about of

named entity 'antibiotic'
named entity 'de-escalation'
named entity 'antimicrobial'
named entity 'CAP'
named entity 'molecular testing'
named entity 'phase IV clinical trial'
named entity 'molecular testing'
named entity 'antibiotic'
named entity 'randomisation'
named entity 'de-escalation'
named entity 'Research Ethics Committee'
named entity 'antibiotic'
named entity 'heart rate'
named entity 'microorganism'
named entity 'Europe'
named entity 'adverse drug events'
named entity 'CAP'
named entity 'antimicrobial stewardship'
named entity 'Clinical Research'
named entity 'Streptococcus pneumoniae'
named entity 'Cox proportional hazards models'
named entity 'follow-up'
named entity 'antibiotic'
named entity 'peer-reviewed'
named entity 'pneumonia'
named entity 'aetiological'
named entity 'CONSORT'
named entity 'oral antibiotics'
named entity 'monotherapy'
named entity 'Informed consent'
named entity 'control group'
named entity 'antimicrobial resistance'
named entity 'antimicrobial therapy'
named entity 'causative agent'
named entity 'infection'
named entity 'intervention trial'
named entity 'intensive care unit'
named entity 'CAP'
named entity 'Community-acquired pneumonia'
named entity 'respiratory rate'
named entity 'complete blood count'
named entity 'antimicrobial'
named entity 'antibiotics'
named entity 'CAP'
named entity 'molecular testing'
named entity 'randomly assigned'
named entity 'antibiotic'
named entity 'Spain'
named entity 'antibiotic therapy'
named entity 'diagnostic process'
named entity 'CAP'
named entity 'antimicrobial'
named entity 'oral antibiotics'
named entity 'Survival time'
named entity 'S. pneumoniae'
named entity 'antimicrobials'
named entity 'mechanical ventilation'
named entity 'ICU'
named entity 'CCI'
named entity 'sodium'
named entity 'quality assurance'
named entity 'Consolidated Standards of Reporting Trials'
named entity 'multidisciplinary teams'
named entity 'Barcelona'
named entity 'amoxicillin'
named entity 'comorbidities'
named entity 'primary endpoint'
named entity 'CCI'
named entity 'autonomous community'
named entity 'nasopharyngeal'
named entity 'phlebitis'
named entity 'antibiotic'
named entity 'experimental subjects'
named entity 'clinical practice'
named entity 'antibiotic'
named entity 'adverse events'
named entity 'blood pressure'
named entity 'study population'
named entity 'Medical Devices Agency'
named entity 'length of hospital stay'
named entity 'length of hospital stay'
named entity 'Randomisation'
named entity 'diagnostic methods'
named entity 'immunochromatographic'
named entity 'CAP'
named entity 'control subjects'
named entity 'intravenous'
named entity 'length of stay'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software